THREE EVALUATIONS OF A MONOAMINE OXIDASE INHIBITOR AND PHENOTHIAZINE COMBINATION (A METHODOLOGICAL AND CLINICAL STUDY).
D001007:Anxiety; D001008:Anxiety Disorders; D035843:Biomedical Research; D003863:Depression; D003866:Depressive Disorder; D004358:Drug Therapy; D006801:Humans; D008996:Monoamine Oxidase Inhibitors; D009497:Neurotic Disorders; D009771:Obsessive-Compulsive Disorder; D010698:Phobic Disorders; D014191:Tranylcypromine; D014268:Trifluoperazine
D008996:Monoamine Oxidase Inhibitors; D014268:Trifluoperazine; D014191:Tranylcypromine
ANXIETY; CLINICAL RESEARCH; DEPRESSION; DRUG THERAPY; NEUROSES; NEUROSES, OBSESSIVE COMPULSIVE; PHOBIAS; TRANYLCYPROMINE; TRIFLUOPERAZINE